Literature Collection

Magnifying Glass
Collection Insights

11K+

References

9K+

Articles

1500+

Grey Literature

4600+

Opioids & SU

The Literature Collection contains over 11,000 references for published and grey literature on the integration of behavioral health and primary care. Learn More

Use the Search feature below to find references for your terms across the entire Literature Collection, or limit your searches by Authors, Keywords, or Titles and by Year, Type, or Topic. View your search results as displayed, or use the options to: Show more references per page; Sort references by Title or Date; and Refine your search criteria. Expand an individual reference to View Details. Full-text access to the literature may be available through a link to PubMed, a DOI, or a URL. References may also be exported for use in bibliographic software (e.g., EndNote, RefWorks, Zotero).

Enter Search Term(s)
Year
Sort by
Order
Show
11248 Results
9241
Studies Examine Growing US Mental Health Safety Net
Type: Report
Authors: New York University
Year: 2024
Publication Place: New York, NY
Topic(s):
Healthcare Policy See topic collection
,
Financing & Sustainability See topic collection
,
Grey Literature See topic collection
,
Healthcare Disparities See topic collection
Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

9242
Study design to evaluate a group-based therapy for support persons of adults on buprenorphine/naloxone
Type: Journal Article
Authors: K. C. Osilla, K. Becker, L. Ecola, B. Hurley, J. K. Manuel, A. Ober, S. M. Paddock, K. E. Watkins
Year: 2020
Abstract:

BACKGROUND: Opioid use disorders (OUDs) have devastating effects on individuals, families, and communities. While medication treatments for OUD save lives and are increasingly utilized, rates of treatment dropout are very high. In addition, most existing medication treatments for OUD may often neglect the impact of untreated OUD on relationships and ignore the potential role support persons (SPs) could have on encouraging long-term recovery, which can also impact patient treatment retention. METHODS/DESIGN: The current study adapts Community Reinforcement and Family Training (CRAFT) for use with SPs (family member, spouse or friend) of patients using buprenorphine/naloxone (buprenorphine) in an outpatient community clinic setting. The study will evaluate whether the adapted intervention, also known as integrating support persons into recovery (INSPIRE), is effective in increasing patient retention on buprenorphine when compared to usual care. We will utilize a two-group randomized design where patients starting or restarting buprenorphine will be screened for support person status and recruited with their support person if eligible. Support persons will be randomly assigned to the INSPIRE intervention, which will consist of 10 rolling group sessions led by two facilitators. Patients and SPs will each be assessed at baseline, 3 months post-baseline, and 12 months post-baseline. Patient electronic medical record data will be collected at six and 12 months post-baseline. We will examine mechanisms of intervention effectiveness and also conduct pre/post-implementation surveys with clinic staff to assess issues that would affect sustainability. DISCUSSION: Incorporating the patient's support system may be an important way to improve treatment retention in medication treatments for OUD. If SPs can serve to support patient retention, this study would significantly advance work to help support the delivery of effective treatments that prevent the devastating consequences associated with OUD. Trial registration This study was registered with ClinicalTrials.gov, NCT04239235. Registered 27 January 2020, https://clinicaltrials.gov/ct2/show/NCT04239235 .

Topic(s):
Opioids & Substance Use See topic collection
9243
Study design to evaluate a group-based therapy for support persons of adults on buprenorphine/naloxone
Type: Journal Article
Authors: Chan Osilla Karen, Kirsten Becker, Liisa Ecola, Brian Hurley, Jennifer K. Manuel, Allison Ober, Susan M. Paddock, Katherine E. Watkins
Year: 2020
Publication Place: London
Topic(s):
Education & Workforce See topic collection
,
Opioids & Substance Use See topic collection
9244
Study of telehealth opioid treatment shows feasibility of remote testing
Type: Journal Article
Authors: Gary Enos
Year: 2023
Topic(s):
Opioids & Substance Use See topic collection
,
HIT & Telehealth See topic collection
9246
Study protocol for a factorial-randomized controlled trial evaluating the implementation, costs, effectiveness, and sustainment of digital therapeutics for substance use disorder in primary care (DIGITS Trial)
Type: Journal Article
Authors: J. E. Glass, C. N. Dorsey, T. Beatty, J. F. Bobb, E. S. Wong, L. Palazzo, D. King, J. Mogk, K. Stefanik-Guizlo, A. Idu, D. Key, J. C. Fortney, R. Thomas, A. G. McWethy, R. M. Caldeiro, K. A. Bradley
Year: 2023
9247
Study protocol for a randomized control trial to investigate the effectiveness of an 8-week mindfulness-integrated cognitive behavior therapy (MiCBT) transdiagnostic group intervention for primary care patients
Type: Journal Article
Authors: Sarah Frances, Frances Shawyer, Bruno Cayoun, Joanne Enticott, Graham Meadows
Year: 2020
Topic(s):
Healthcare Disparities See topic collection
,
Measures See topic collection
9248
Study protocol for the COMET study: a cluster-randomised, prospective, parallel-group, superiority trial to compare the effectiveness of a collaborative and stepped care model versus treatment as usual in patients with mental disorders in primary care
Type: Journal Article
Authors: D. Heddaeus, J. Dirmaier, C. Brettschneider, A. Daubmann, T. Grochtdreis, von dem Knesebeck, H. H. Konig, B. Lowe, K. Maehder, S. Porzelt, M. Rosenkranz, I. Schafer, M. Scherer, B. Schulte, K. Wegscheider, A. Weigel, S. Werner, T. Zimmermann, M. Harter
Year: 2019
Publication Place: England
Topic(s):
General Literature See topic collection
9249
Study protocol of the ESUB-MG cluster randomized trial: a pragmatic trial assessing the implementation of urine drug screening in general practice for buprenorphine maintained patients
Type: Journal Article
Authors: ESUB-MG Study Group
Year: 2016
Publication Place: England
Abstract: BACKGROUND: In addiction care, urine drug screening tests are recommended to assess psychoactive substances use. While intrinsic diagnostic value of these tests is demonstrated, the consequences of carrying out these tests on opiate maintenance treatment (OMT) have not been established. The main objective will be to assess the impact of on-site urine drug screening tests (OS-UDS) in general practice compared to routine medical care on OMT retention at 6 months in opioid-dependent patients initiating buprenorphine. METHODS/DESIGN: The ESUB-MG study uses a pragmatic, cluster randomized controlled trial design. General Practitioners (GPs) regularly managing patients treated with buprenorphine and consenting for participating will be invited to participate. GPs will be randomly assigned to one of two groups for 6 to 24 months: (a) control group (usual care: standard medical strategy for assessing drug use); (b) interventional group (including 1/ a training session on practice and interpretation of OS-UDS; 2/ the supply of OS-UDS at GPs' medical offices; 3/ performing an OS-UDS before the first prescription of buprenorphine). GPs will have to include 1 to 10 patients aged 18 years-old or more, consulting for starting treatment by buprenorphine, not opposed to participate. The primary outcome will be OMT retention at 6 months. DISCUSSION: This randomized interventional trial should bring sufficient level of evidence to assess effectiveness of performing OS-UDS in general practice for patients treated by buprenorphine. Training GPs to drug tests and supplying them in their office should lead to an improvement of opioid-addicted patients' care through helping decision. TRIALS REGISTRATION: NCT02345655 (first registration May 14, 2014).
Topic(s):
Opioids & Substance Use See topic collection
9250
Study to promote innovation in rural integrated telepsychiatry (SPIRIT): Rationale and design of a randomized comparative effectiveness trial of managing complex psychiatric disorders in rural primary care clinics
Type: Journal Article
Authors: J. C. Fortney, P. J. Heagerty, A. M. Bauer, J. M. Cerimele, D. Kaysen, P. N. Pfeiffer, M. J. Zielinski, J. M. Pyne, D. Bowen, J. Russo, L. Ferro, D. Moore, J. P. Nolan, F. C. Fee, T. Heral, J. Freyholtz-London, B. McDonald, J. Mullins, E. Hafer, L. Solberg, J. Unutzer
Year: 2019
Publication Place: United States
Topic(s):
Healthcare Disparities See topic collection
,
HIT & Telehealth See topic collection
9251
Study to promote innovation in rural integrated telepsychiatry (SPIRIT): Rationale and design of a randomized comparative effectiveness trial of managing complex psychiatric disorders in rural primary care clinics
Type: Journal Article
Authors: J. C. Fortney, P. J. Heagerty, A. M. Bauer, J. M. Cerimele, D. Kaysen, P. N. Pfeiffer, M. J. Zielinski, J. M. Pyne, D. Bowen, J. Russo, L. Ferro, D. Moore, J. P. Nolan, F. C. Fee, T. Heral, J. Freyholtz-London, B. McDonald, J. Mullins, E. Hafer, L. Solberg, J. Unutzer
Year: 2020
Publication Place: United States
Topic(s):
Financing & Sustainability See topic collection
,
Healthcare Disparities See topic collection
,
HIT & Telehealth See topic collection
,
Measures See topic collection
9252
Studying and facilitating the development, installation, and initial implementation of an interdisciplinary buprenorhine treatment/practice with a publicly funded, HIV primary care, designated AIDS center in New York City
Type: Web Resource
Authors: Nancy Murphy
Year: 2014
Topic(s):
Opioids & Substance Use See topic collection
,
Grey Literature See topic collection
Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

9253
Subjective effects of prisoners using buprenorphine for detoxification
Type: Journal Article
Authors: Alexander Johnstone, Tim Duffy, Colin Martin
Year: 2011
Topic(s):
Opioids & Substance Use See topic collection
,
Healthcare Disparities See topic collection
9254
Subjective memory complaints in general practice predicts future dementia: a 4-year follow-up study
Type: Journal Article
Authors: Frans Boch Waldorff, Volkert Siersma, Asmus Vogel, Gunhild Waldemar
Year: 2012
Topic(s):
General Literature See topic collection
9255
Subjective social status and mindful attention in terms of anxiety and depressive symptoms and disorders among Latinos in primary care
Type: Journal Article
Authors: Michael J. Zvolensky, Daniel J. Paulus, Jafar Bakshaie, Andres G. Viana, Lorraine R. Reitzel, Monica Garza, Jodi Berger Cardoso, Melissa Ochoa-Perez, Lia J. Smith, Chad Lemaire, Kara Manning, Andrew H. Rogers
Year: 2018
Topic(s):
Healthcare Disparities See topic collection
9256
Subjective social status and rumination in relation to anxiety and depressive symptoms and psychopathology among economically disadvantaged Latinos in primary care
Type: Journal Article
Authors: David C. Talavera, Daniel J. Paulus, Monica Garza, Melissa Ochoa-Perez, Chad Lemaire, Jeanette Valdivieso, Daniel Bogiaizian, Zuzuky Robles, Jafar Bakhshaie, Kara Manning, Rheeda Walker, Michael Businelle, Michael J. Zvolensky
Year: 2018
Topic(s):
Healthcare Disparities See topic collection
9257
Subjective symptoms and serum methadone concentrations: what should guide dose adjustments in methadone maintenance treatment? A naturalistic cohort study from Norway
Type: Journal Article
Authors: F. Chalabianloo, L. T. Fadnes, G. Høiseth, C. Ohldieck, J. H. Vold, C. Aas, E. M. Løberg, K. A. Johansson, J. G. Bramness
Year: 2021
Abstract:

BACKGROUND: There is little evidence-based guidance on how to optimize methadone dosages among patients with opioid addiction undergoing methadone maintenance treatment (MMT). This study aims to investigate whether self-perceived opioid withdrawal symptoms, adverse effects, and self-reported substance use in patients on MMT are related to serum methadone concentrations and the role that these variables could play in clinical decisions on dose adjustments. METHODS: This naturalistic prospective cohort study included clinical and laboratory measurements from 83 patients undergoing MMT in outpatient clinics in Bergen, Norway, from May 2017 to January 2020. Information on age, gender, methadone daily doses and serum concentrations, subjective opioid withdrawal symptoms using 16 items Subjective Opioid Withdrawal Scale (SOWS) questionnaire, self-reported adverse effects, and substance use was obtained. Linear mixed modelling was used for analyzing the data. RESULTS: The mean age of the participants was 45 years, and 33% were women. Almost half reported mild to moderate subjective opioid withdrawal symptoms, and all had experienced at least one subjective adverse effect. The use of at least one substance was reported by 88% of the participants. Serum concentration-to-dose ratios were lower among those who had reported subjective opioid withdrawal symptoms (p) = 0.039). The total SOWS score (p < 0.001); the specific subjective withdrawal symptoms of anxiety (p = 0.004), bone and muscle aches (p = 0.003), restlessness (p = 0.017), and (slightly) shaking (p = 0.046), also use of heroin (p = 0.015) and alcohol (p = 0.011) were associated with lower methadone concentrations. Cannabis use was slightly related to higher methadone concentrations (p = 0.049). CONCLUSIONS: The findings suggest that the patient's self-perceived symptoms and current clinical condition are related to the serum concentrations of methadone. This interpretation supports dose adjustments based on patient-reported symptoms. In some aberrant cases, measurement of serum concentrations together with other individual assessments may be considered to support the clinical decision.

Topic(s):
Measures See topic collection
,
Opioids & Substance Use See topic collection
9258
Suboptimal nonmedical qualities of primary care linked with care avoidance among people who use drugs in a Canadian setting amid an integrated health care reform
Type: Journal Article
Authors: Soroush Moallef, Laura Dale, Fahmida Homayra, Cristy Zonneveld, M. J. Milloy, Bohdan Nosyk, Kanna Hayashi
Year: 2022
Topic(s):
Opioids & Substance Use See topic collection
,
Healthcare Disparities See topic collection
9259
Suboptimal Opioid Prescribing: A Practice Change Project
Type: Journal Article
Authors: L. S. Young, R. S. Crausman, J. P. Fulton
Year: 2018
Publication Place: United States
Abstract: In the U.S. in 2015, the proportion of people dependent on opioids approached one percent, and opioid overdose rivaled auto accidents as the leading cause of accidental death. The literature suggests a credible link between increased opioid prescribing and increased opioid addiction. Accordingly, some have suggested that limiting the number of opioid prescriptions (and the number of doses per prescription) might be effective in reducing the number of opioid-related deaths. Toward this end, we designed and piloted an evidence-based quality-improvement project in four urgent care clinics. Results of the intervention were monitored with data from a state-sponsored prescription drug-monitoring program (PDMP) by comparing opioid prescribing before and after adoption of the guideline, and in this manner, a statistically significant (P < 0.05) decline in the rate of opioid prescribing was revealed. On average, 2.43 fewer opioid prescriptions were written, per provider, per week, in weeks five through eight after promulgation (5.21, SD =4.37) than in the eight weeks before promulgation (7.64, SD =7.73). Our results suggest that implementing a simple opioid-prescribing guideline, with monitoring, can reduce sub-optimal opioid prescribing, and therefore the volume of opioids available in the community for diversion, abuse, and addiction.
Topic(s):
Opioids & Substance Use See topic collection
9260
Substance Abuse and Mental Health Services Administration (SAMHSA)
Type: Web Resource
Authors: Substance Abuse and Mental Health Services Administration
Year: 2013
Topic(s):
Grey Literature See topic collection
Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.